1. Home
  2. |Insights
  3. |EEOC Tells Court that Employers Could Be Required to Submit EEO-1 Pay Data by September 30

EEOC Tells Court that Employers Could Be Required to Submit EEO-1 Pay Data by September 30

Client Alert | 1 min read | 04.04.19

In response to an April 3 court-ordered deadline to provide further guidance to employers regarding their EEO-1 filing obligations, the EEOC filed a submission with the court yesterday proposing that employers be required to submit 2018 EEO-1 compensation data by September 30, 2019. The agency indicated that it will hire a contractor, at a cost of over $3 million, to collect the data “including providing the processes, procedures and systems to undertake and close the collection by September 30, 2019.” The EEOC is awaiting a ruling on whether its proposal is acceptable, and has not, as yet, provided any further guidance to employers about the process, so stay tuned for further details in the coming days.

Contacts

Insights

Client Alert | 9 min read | 10.21.26

Artificial Intelligence in Life Sciences: Reliability of AI-Generated Evidence in Drug Discovery and Development

The life sciences sector is uniquely vulnerable to the inherent risks of AI-generated evidence in drug development and discovery. This client alert focuses on five core challenges: hallucinations, skewed predictions from unrepresentative training data, the opacity of AI reasoning, input sensitivity that undermines reproducibility, and adversarial manipulation of training data. To address these risks, companies should use experimental validation and human oversight as the common legal and regulatory safety net. This entails among other measures auditing AI outputs, characterizing training data, and structural oversight. Companies also should prepare for evolving frameworks and guidance from the U.S. Food and Drug Administration (FDA) and the European Union (EU) that address use of AI in drug discovery and development .  ...